세계의 동물 감염병 진단 시장 : 제품별, 기술별, 동물 유형별, 최종 사용자별, 지역별 예측(-2030년)

The veterinary infectious disease diagnostics market is expected to grow from USD 2.87 billion in 2025 to USD 4.22 billion by 2030, at a CAGR of 8.0%. This growth is driven by several important factors that reflect the changing landscape of animal health and disease management.

One primary driver is the increasing burden of infectious diseases among both companion animals and livestock, which has heightened the need for rapid, reliable, and field-deployable diagnostic solutions. The rise in outbreaks of diseases such as avian influenza, leptospirosis, and brucellosis is leading veterinarians and animal producers to prioritize early and accurate detection to mitigate risks.

Another significant factor is the shift towards preventive veterinary care. As awareness grows among pet owners and livestock handlers, there is a stronger emphasis on routine screenings and health monitoring to identify infections before they escalate. This trend is also supported by a growing recognition of the economic and public health consequences associated with the transmission of zoonotic diseases.

"By animal type, the companion animals segment is projected to grow at the highest CAGR during the forecast period."

The companion animals segment is expected to see the highest growth in the veterinary infectious disease diagnostics market, driven by increasing pet ownership, especially in urban high-income households. Pet owners are more willing to invest in health check-ups and diagnostic services due to the growing awareness of zoonotic diseases and the importance of early detection. Additionally, innovations in point-of-care and home-based diagnostic tools enhance access for both pet owners and veterinarians. With more frequent visits to veterinary clinics and rising healthcare spending for pets, this segment is projected for rapid growth in the market.

"By technology, the immunodiagnostics segment accounted for the largest market share in 2024."

In 2024, the immunodiagnostics segment dominated the veterinary infectious disease diagnostics market due to its cost-effectiveness and high accuracy. Techniques like ELISA and lateral flow assays are commonly used to detect various infectious diseases in companion and livestock animals. These tests provide rapid results, are user-friendly, and require minimal equipment, making them ideal for veterinary clinics and field use. Their ability to detect specific antigens or antibodies enables early diagnosis and effective disease management, making them valuable for large population screenings and routine surveillance programs.

"The Asia Pacific region is expected to witness the highest growth rate during the forecast period."

The Asia Pacific is set to experience the highest growth in the veterinary infectious disease diagnostics market due to various demographic, economic, and healthcare factors. The region's large livestock population drives the demand for accurate diagnostics to address rising infectious diseases like foot-and-mouth disease and avian influenza. Additionally, the increasing number of companion animals, especially in urban areas of China and India, is boosting veterinary healthcare spending. Enhanced veterinary infrastructure, heightened awareness of zoonotic threats, and investments in animal health are also contributing to market growth. Companies are expanding their presence in the region to improve access to advanced diagnostic technologies.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
• By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

• By End User: Veterinary Reference Laboratories (40%), Veterinary Hospitals & Clinics (25%), POC/In-house Testing (20%), and Veterinary Research Institutes & Universities (15%)
• By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Research Coverage

The market study covers the veterinary infectious disease diagnostics market in various segments. It aims to estimate the market size and growth potential of this market by product, technology, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:

• Analysis of key drivers (growth in companion animal population, increasing demand for animal-derived food products, growing concerns about infectious zoonotic diseases, rising demand for pet insurance and growing animal health expenditures, increasing number of veterinary practitioners and rising income levels in developed markets, and growing focus on disease control and prevention measures), restraints (rising pet care costs and high cost of veterinary diagnostic tests), opportunities (growth potential of emerging economies and integration of AI and ML), and challenges (low animal healthcare awareness in emerging countries and shortage of veterinary practitioners in emerging economies) influencing the growth of the veterinary infectious disease diagnostics market.
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the veterinary infectious disease diagnostics market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary infectious disease diagnostic products across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary infectious disease diagnostics market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary infectious disease diagnostics market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 MARKET STAKEHOLDERS
• 1.5 LIMITATIONS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
• 2.2 RESEARCH METHODOLOGY DESIGN
  • 2.2.1 SECONDARY RESEARCH
    • 2.2.1.1 Key data from secondary sources
  • 2.2.2 PRIMARY DATA
    • 2.2.2.1 Key data from primary sources
    • 2.2.2.2 Key industry insights
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 BOTTOM-UP APPROACH
• 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.5 MARKET SHARE ESTIMATION
• 2.6 RESEARCH ASSUMPTIONS
• 2.7 RISK ASSESSMENT
• 2.8 RESEARCH LIMITATIONS
  • 2.8.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.8.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
• 4.2 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & COUNTRY (2024)
• 4.3 INFECTIOUS DISEASE DIAGNOSTICS MARKET: REGIONAL MIX
• 4.4 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.5 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 MARKET DYNAMICS
  • 5.1.1 DRIVERS
    • 5.1.1.1 Growth in companion animal population
    • 5.1.1.2 Increasing demand for animal-derived food products
    • 5.1.1.3 Growing concerns about infectious zoonotic diseases
    • 5.1.1.4 Rising demand for pet insurance and growing animal health expenditure
    • 5.1.1.5 Increasing number of veterinary practitioners and rising income levels in developed markets
    • 5.1.1.6 Growing focus on disease control & prevention measures
  • 5.1.2 RESTRAINTS
    • 5.1.2.1 Rising pet care costs
    • 5.1.2.2 High cost of veterinary diagnostic tests
  • 5.1.3 OPPORTUNITIES
    • 5.1.3.1 Growth potential of emerging economies
    • 5.1.3.2 Integration of AI & ML
  • 5.1.4 CHALLENGES
    • 5.1.4.1 Low animal healthcare awareness in emerging countries
    • 5.1.4.2 Shortage of veterinary practitioners in emerging economies
• 5.2 INDUSTRY TRENDS
  • 5.2.1 ADOPTION OF MULTIPLE TEST PANELS
  • 5.2.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
  • 5.2.3 GROWING SCALE OF VETERINARY BUSINESSES
• 5.3 TECHNOLOGY ANALYSIS
  • 5.3.1 KEY TECHNOLOGIES
    • 5.3.1.1 Portable instruments for POC diagnostic services
    • 5.3.1.2 Biosensor-based diagnostic systems
  • 5.3.2 ADJACENT TECHNOLOGIES
    • 5.3.2.1 Wearable biosensors & remote monitoring devices
    • 5.3.2.2 Rapid & sensitive veterinary diagnostic kits
    • 5.3.2.3 Breath & saliva-based diagnostic tools
    • 5.3.2.4 Microfluidics & Lab-on-a-chip devices
  • 5.3.3 COMPLEMENTARY TECHNOLOGIES
    • 5.3.3.1 AI-driven diagnostic platforms
    • 5.3.3.2 Next-generation sequencing (NGS)
• 5.4 PORTER'S FIVE FORCES ANALYSIS
  • 5.4.1 THREAT OF NEW ENTRANTS
  • 5.4.2 THREAT OF SUBSTITUTES
  • 5.4.3 BARGAINING POWER OF SUPPLIERS
  • 5.4.4 BARGAINING POWER OF BUYERS
  • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.5 REGULATORY ANALYSIS
  • 5.5.1 REGULATORY LANDSCAPE
  • 5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.5.2.1 North America
    • 5.5.2.2 Europe
    • 5.5.2.3 Rest of the World
• 5.6 PATENT ANALYSIS
  • 5.6.1 PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
  • 5.6.2 JURISDICTION & TOP APPLICANT ANALYSIS
• 5.7 TRADE ANALYSIS
  • 5.7.1 TRADE DATA FOR HS CODE 9018
    • 5.7.1.1 Import data for HS Code 9018
    • 5.7.1.2 Export data for HS Code 9018
• 5.8 PRICING ANALYSIS
  • 5.8.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022-2024
  • 5.8.2 AVERAGE SELLING PRICE, BY REGION, 2022-2024
    • 5.8.2.1 Average selling price of ELISA and PCR test kits, by region, 2024
    • 5.8.2.2 Average selling price trend of ELISA test kits (per 96-well kit), by region, 2022-2024
    • 5.8.2.3 Average selling price trend of lateral flow rapid tests (per unit), by region, 2022-2024
    • 5.8.2.4 Average selling price trend of PCR test kits (veterinary panels), by region, 2022-2024
    • 5.8.2.5 Average selling price trend of immunoassay analyzers (benchtop), by region, 2022-2024
    • 5.8.2.6 Average selling price trend of high-end immunoassay analyzers, by region, 2022-2024
    • 5.8.2.7 Average selling price trend of nucleic acid sequencers (benchtop), by region, 2022-2024
• 5.9 REIMBURSEMENT ANALYSIS
• 5.10 KEY CONFERENCES & EVENTS, 2025-2026
• 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.11.2 BUYING CRITERIA
• 5.12 END-USER PERSPECTIVE & UNMET NEEDS
• 5.13 IMPACT OF AI ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
  • 5.13.1 INTRODUCTION
  • 5.13.2 MARKET POTENTIAL IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS ECOSYSTEM
  • 5.13.3 AI USE CASES
  • 5.13.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
• 5.14 ECOSYSTEM ANALYSIS
• 5.15 VALUE CHAIN ANALYSIS
• 5.16 SUPPLY CHAIN ANALYSIS
• 5.17 ADJACENT MARKET ANALYSIS
• 5.18 INVESTMENT & FUNDING SCENARIO
• 5.19 IMPACT OF 2025 US TARIFF ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
  • 5.19.1 INTRODUCTION
  • 5.19.2 KEY TARIFF RATES
  • 5.19.3 PRICE IMPACT ANALYSIS
  • 5.19.4 IMPACT ON COUNTRY/REGION
  • 5.19.5 IMPACT ON END-USE INDUSTRIES

6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 CONSUMABLES
  • 6.2.1 RECURRENT PURCHASE OF DIAGNOSTIC KITS AND REAGENTS TO BOOST MARKET GROWTH
• 6.3 INSTRUMENTS
  • 6.3.1 INCREASING DEMAND FOR POC ANALYZERS TO SUPPORT MARKET GROWTH

7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY

• 7.1 INTRODUCTION
• 7.2 IMMUNODIAGNOSTICS
  • 7.2.1 LATERAL FLOW ASSAYS
    • 7.2.1.1 Lateral flow rapid tests
      • 7.2.1.1.1 Ability to provide real-time insights to drive market
    • 7.2.1.2 Lateral flow strip readers
      • 7.2.1.2.1 Rising need for readers to determine analyte quantity to fuel adoption
  • 7.2.2 ELISA TESTS
    • 7.2.2.1 Cost-effectiveness and ease of use to drive market
  • 7.2.3 IMMUNOASSAY ANALYZERS
    • 7.2.3.1 High sensitivity & specificity for biomarker detection to drive market
  • 7.2.4 OTHER IMMUNODIAGNOSTIC TECHNOLOGIES
• 7.3 MOLECULAR DIAGNOSTICS
  • 7.3.1 PCR TESTS
    • 7.3.1.1 Increased laboratory usage in proteomics & genomics to support growth
  • 7.3.2 NUCLEIC ACID SEQUENCING
    • 7.3.2.1 Growing use of nucleic acid sequencing to identify pathogens to fuel market
  • 7.3.3 MICROARRAYS
    • 7.3.3.1 Growing applications of biochips in identifying infectious diseases to drive market
  • 7.3.4 OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
• 7.4 OTHER TECHNOLOGIES

8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE

• 8.1 INTRODUCTION
• 8.2 COMPANION ANIMALS
  • 8.2.1 COMPANION ANIMALS MARKET, BY ANIMAL TYPE
    • 8.2.1.1 Dogs
      • 8.2.1.1.1 High insurance coverage for dogs and rising disposable incomes to drive market
    • 8.2.1.2 Cats
      • 8.2.1.2.1 Growing pet cat population to support growth
    • 8.2.1.3 Horses
      • 8.2.1.3.1 Growing equine health awareness to drive market
    • 8.2.1.4 Other companion animals
  • 8.2.2 COMPANION ANIMALS MARKET, BY TECHNOLOGY
    • 8.2.2.1 Immunodiagnostics
      • 8.2.2.1.1 Lateral flow assays
        • 8.2.2.1.1.1 Rapid results, no requirement for multiple sample batches, and ease of visual reading to drive market growth
      • 8.2.2.1.2 ELISA tests
        • 8.2.2.1.2.1 High sensitivity, specificity, and precision of ELISA tests to drive market
      • 8.2.2.1.3 Immunoassay analyzers
        • 8.2.2.1.3.1 Ability to process multiple samples to drive adoption of immunoassay analyzers
      • 8.2.2.1.4 Other immunodiagnostic technologies
    • 8.2.2.2 Molecular diagnostics
      • 8.2.2.2.1 PCR tests
        • 8.2.2.2.1.1 Extensive use of PCR due to its high specificity and sensitivity to boost adoption
      • 8.2.2.2.2 Nucleic acid sequencing
        • 8.2.2.2.2.1 Increasing use of nucleic acid sequencing for pathogen discovery and identification to support growth
      • 8.2.2.2.3 Microarrays
        • 8.2.2.2.3.1 Technological advancements and increasing incidence of infectious diseases to fuel demand for microarrays
      • 8.2.2.2.4 Other molecular diagnostic technologies
    • 8.2.2.3 Other technologies
• 8.3 LIVESTOCK
  • 8.3.1 LIVESTOCK MARKET, BY ANIMAL TYPE
    • 8.3.1.1 Cattle
      • 8.3.1.1.1 Growing consumption of meat to support market growth
    • 8.3.1.2 Pigs
      • 8.3.1.2.1 Growing incidence of infectious diseases to drive market
    • 8.3.1.3 Poultry
      • 8.3.1.3.1 Increasing demand for poultry meat to contribute to market growth
    • 8.3.1.4 Other livestock
  • 8.3.2 LIVESTOCK MARKET, BY TECHNOLOGY
    • 8.3.2.1 Immunodiagnostics
      • 8.3.2.1.1 Lateral flow assays
        • 8.3.2.1.1.1 Field-readiness and stakeholder accessibility of LFAs to boost demand
      • 8.3.2.1.2 ELISA tests
        • 8.3.2.1.2.1 Cost-effectiveness, high sensitivity, and ease of use to drive ELISA market
      • 8.3.2.1.3 Immunoassay analyzers
        • 8.3.2.1.3.1 High sensitivity & specificity for biomarker detection to drive market
      • 8.3.2.1.4 Other immunodiagnostic technologies
    • 8.3.2.2 Molecular diagnostics
      • 8.3.2.2.1 PCR tests
        • 8.3.2.2.1.1 Growing use of PCR in proteomics and genomics to drive market growth
      • 8.3.2.2.2 Nucleic acid sequencing
        • 8.3.2.2.2.1 Identification of pathogens to fuel market
      • 8.3.2.2.3 Microarrays
        • 8.3.2.2.3.1 Emergence of biochips and growing applications in identifying infectious diseases to drive growth
      • 8.3.2.2.4 Other molecular diagnostic technologies
    • 8.3.2.3 Other technologies

9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 VETERINARY REFERENCE LABORATORIES
  • 9.2.1 LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET
• 9.3 VETERINARY HOSPITALS & CLINICS
  • 9.3.1 GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET
• 9.4 POINT-OF-CARE/IN-HOUSE TESTING
  • 9.4.1 COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND
• 9.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
  • 9.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH

10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 High veterinary healthcare expenditure to drive market
  • 10.2.3 CANADA
    • 10.2.3.1 Growing pet adoption to drive market
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Rising awareness of zoonotic diseases to fuel market
  • 10.3.3 UK
    • 10.3.3.1 Increasing pet ownership to drive market
  • 10.3.4 FRANCE
    • 10.3.4.1 Willingness of pet owners to spend on pet health to drive market
  • 10.3.5 ITALY
    • 10.3.5.1 Growing consumption of meat & dairy products to drive market
  • 10.3.6 SPAIN
    • 10.3.6.1 Growing demand for poultry products to fuel market
  • 10.3.7 NETHERLANDS
    • 10.3.7.1 Developments in veterinary diagnostic products to support market growth
  • 10.3.8 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 Increasing incidence of zoonotic diseases to propel market
  • 10.4.3 JAPAN
    • 10.4.3.1 Increasing pet expenditure to support market growth
  • 10.4.4 INDIA
    • 10.4.4.1 Increasing demand for dairy products to drive market
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Rise in pet ownership to support market growth
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Rising need for specialized veterinary services to drive market
  • 10.4.7 NEW ZEALAND
    • 10.4.7.1 Focus on pet insurance to aid market
  • 10.4.8 VIETNAM
    • 10.4.8.1 Growing focus on disease surveillance to drive market
  • 10.4.9 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Growth in livestock industry to boost demand
  • 10.5.3 MEXICO
    • 10.5.3.1 Increasing focus on poultry-associated products to support market growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Kingdom of Saudi Arabia (KSA)
      • 10.6.2.1.1 Technological advancements in veterinary diagnostics to boost demand
    • 10.6.2.2 United Arab Emirates (UAE)
      • 10.6.2.2.1 Favorable government support for vet diagnostics to drive market
    • 10.6.2.3 Rest of GCC Countries
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
• 11.3 REVENUE ANALYSIS, 2020-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.4.1 MARKET SHARE ANALYSIS FOR COMPANION ANIMALS
  • 11.4.2 MARKET SHARE ANALYSIS FOR LIVESTOCK
  • 11.4.3 RANKING OF KEY MARKET PLAYERS
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Product footprint
    • 11.5.5.4 Technology footprint
    • 11.5.5.5 Animal type footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 11.6.5.1 Detailed list of key startups/SMEs
    • 11.6.5.2 Competitive benchmarking of key startups
• 11.7 BRAND/PRODUCT COMPARISON
• 11.8 R&D EXPENDITURE OF KEY PLAYERS
• 11.9 COMPANY VALUATION & FINANCIAL METRICS
  • 11.9.1 FINANCIAL METRICS
  • 11.9.2 COMPANY VALUATION
• 11.10 COMPETITIVE SCENARIO
  • 11.10.1 PRODUCT LAUNCHES & ENHANCEMENTS
  • 11.10.2 DEALS
  • 11.10.3 EXPANSIONS
  • 11.10.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 IDEXX LABORATORIES, INC.
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products & services offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product/Service launches & enhancements
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 ZOETIS SERVICES LLC
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products & services offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product enhancements
      • 12.1.2.3.2 Deals
      • 12.1.2.3.3 Expansions
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 THERMO FISHER SCIENTIFIC INC.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products & services offered
    • 12.1.3.3 MnM view
      • 12.1.3.3.1 Key strengths
      • 12.1.3.3.2 Strategic choices
      • 12.1.3.3.3 Weaknesses & competitive threats
  • 12.1.4 VIRBAC
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products & services offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Deals
      • 12.1.4.3.2 Expansions
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 BIOMERIEUX
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products & services offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches & approvals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses & competitive threats
  • 12.1.6 ANTECH DIAGNOSTICS, INC.
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products & services offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product launches
      • 12.1.6.3.2 Expansions
  • 12.1.7 INNOVATIVE DIAGNOSTICS
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products & services offered
  • 12.1.8 NEOGEN CORPORATION
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products & services offered
      • 12.1.8.2.1 Other developments
  • 12.1.9 INDICAL BIOSCIENCE GMBH
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products & services offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product enhancements
  • 12.1.10 AGROLABO S.P.A.
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products & services offered
  • 12.1.11 BIONOTE
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products & services offered
    • 12.1.11.3 Recent developments
    • 12.1.11.4 Product launches
      • 12.1.11.4.1 Deals
  • 12.1.12 BIOGAL
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products & services offered
  • 12.1.13 BIOCHEK
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products & services offered
    • 12.1.13.3 Recent developments
      • 12.1.13.3.1 Product launches
      • 12.1.13.3.2 Deals
  • 12.1.14 MEGACOR DIAGNOSTIK GMBH
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products & services offered
    • 12.1.14.3 Recent developments
      • 12.1.14.3.1 Product launches & enhancements
  • 12.1.15 BIO-RAD LABORATORIES, INC.
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products & services offered
• 12.2 OTHER PLAYERS
  • 12.2.1 FASSISI, GMBH
  • 12.2.2 BIOTANGENTS LIMITED
  • 12.2.3 SKYER, INC.
  • 12.2.4 BIOPANDA REAGENTS LTD.
  • 12.2.5 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
  • 12.2.6 GOLD STANDARD DIAGNOSTICS
  • 12.2.7 BIO-X DIAGNOSTICS S.A.
  • 12.2.8 DEMEDITEC DIAGNOSTICS GMBH
  • 12.2.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
  • 12.2.10 BIOSTONE ANIMAL HEALTH

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 RELATED REPORTS
• 13.4 AUTHOR DETAILS